The study showed a reduced incidence of adverse effects and a decreasing trend in leukotriene levels among both the RIT and conventional immunotherapy groups, suggesting comparable safety profiles.
1
—
—
The study showed a reduced incidence of adverse effects and a decreasing trend in leukotriene levels among both the RIT and conventional immunotherapy groups, suggesting comparable safety profiles.